Kliniske studier for Psoriasis i Kentucky
4 studier for Psoriasis søker deltakere på steder i Kentucky.
Offisiell studietekst (engelsk)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of Kentucky/Markey Cancer Center, Lexington
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT03816345A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Equity Medical - Bowling Green, Bowling Green
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT06857942A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Kentucky Advanced Medical Research LLC, Murray
RekruttererFase 3
Alder 12 til 17 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06979453A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
- Study Center, Louisville
RekruttererFase 2
Alder 18 til 70 · Alle kjønn · Oppdatert 9. jul. 2026 · NCT07489885Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.